UMN Pharma Inc. announced consolidated earnings results for the first quarter ended March 31, 2017. For the period, the company reported net sales of ¥2,943,000. Operating loss was ¥141,129,000. Income before income taxes was ¥206,650,000. Net income was ¥206,491,000. Net cash used in operating activities was ¥121,014,000. Net income per basic share of ¥16.94.

For the year, the company forecasts net sales of ¥153 million; operating loss of ¥512 million; ordinary loss of ¥167 million; net loss of ¥170 million and loss per share of ¥13.96.